Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: "Paul Schimmel" Clear advanced filters
  • Aminoacyl tRNA synthetases (aaRSs) have progressively added domains and motifs that have no connection to aminoacylation. These additions equip aaRSs with new functions and correlate with the appearance of new biological processes (such as a circulatory system) during the course of evolution.

    • Min Guo
    • Xiang-Lei Yang
    • Paul Schimmel
    Reviews
    Nature Reviews Molecular Cell Biology
    Volume: 11, P: 668-674
  • Biologist who discovered ribosome clusters and 'left-handed' DNA.

    • Paul Schimmel
    Comments & Opinion
    Nature
    Volume: 521, P: 291
  • Two papers present strong evidence that the codon-anticodon interaction is poised on a tipping point so that, given a nudge, the tRNA can insert the wrong amino acid into the growing polypeptide chain, leading to translational fidelity loss.

    • Paul Schimmel
    • Min Guo
    News & Views
    Nature Structural & Molecular Biology
    Volume: 16, P: 348-349
  • tRNAs exist as diverse species, including sequence isoforms and nuclease-generated fragments, which are further functionally diversified by base modifications and various protein interactions. Perhaps unsurprisingly, tRNAs are now being implicated in various cellular processes beyond protein synthesis per se, including in stress responses, proliferation, cell fate determination and tumorigenesis.

    • Paul Schimmel
    Reviews
    Nature Reviews Molecular Cell Biology
    Volume: 19, P: 45-58
  • Natural products comprised of a macrocycle ring structure have proven their therapeutic applications as antibiotics, immunosuppressants as well as anticancer agents. Despite this, macrocyclic compounds remain under-explored. Terrett and colleagues review the properties and features of current macrocycle drugs, emphasizing the vast potential of synthetic macrocyles in drug discovery.

    • Edward M. Driggers
    • Stephen P. Hale
    • Nicholas K. Terrett
    Reviews
    Nature Reviews Drug Discovery
    Volume: 7, P: 608-624